BSE Live
Dec 05, 16:01Prev. Close
948.85
Open Price
947.15
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 05, 15:59Prev. Close
949.25
Open Price
945.00
Bid Price (Qty.)
933.60 (3)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Natco Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 105.26 | 77.34 | 39.18 | 9.32 | 24.20 | |
| Diluted EPS (Rs.) | 105.26 | 77.34 | 39.18 | 9.32 | 24.16 | |
| Cash EPS (Rs.) | 118.36 | 87.99 | 48.17 | 17.13 | 30.65 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 424.97 | 326.99 | 267.06 | 233.62 | 225.94 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 424.97 | 326.99 | 267.06 | 233.62 | 225.94 | |
| Revenue from Operations/Share (Rs.) | 247.46 | 223.40 | 148.33 | 106.56 | 112.44 | |
| PBDIT/Share (Rs.) | 142.49 | 105.00 | 57.00 | 19.86 | 38.89 | |
| PBIT/Share (Rs.) | 129.35 | 94.56 | 48.02 | 12.05 | 32.49 | |
| PBT/Share (Rs.) | 128.01 | 93.49 | 47.23 | 11.08 | 31.76 | |
| Net Profit/Share (Rs.) | 105.22 | 77.56 | 39.19 | 9.32 | 24.24 | |
| NP After MI And SOA / Share (Rs.) | 105.33 | 77.56 | 39.19 | 9.32 | 24.16 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 57.57 | 47.00 | 38.42 | 18.63 | 34.58 | |
| PBIT Margin (%) | 52.27 | 42.33 | 32.37 | 11.30 | 28.89 | |
| PBT Margin (%) | 51.73 | 41.85 | 31.83 | 10.39 | 28.24 | |
| Net Profit Margin (%) | 42.51 | 34.71 | 26.42 | 8.74 | 21.55 | |
| NP After MI And SOA Margin (%) | 42.56 | 34.71 | 26.42 | 8.74 | 21.48 | |
| Return on Networth/Equity (%) | 24.78 | 23.71 | 14.67 | 3.98 | 10.69 | |
| Return on Capital Employed (%) | 30.11 | 28.52 | 17.61 | 4.99 | 13.89 | |
| Return on Assets (%) | 21.84 | 20.10 | 12.64 | 3.32 | 9.20 | |
| Total Debt/Equity (X) | 0.04 | 0.06 | 0.03 | 0.09 | 0.06 | |
| Asset Turnover Ratio (%) | 0.57 | 0.64 | 0.50 | 0.36 | 0.35 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 5.59 | 4.14 | 4.39 | 3.52 | 4.45 | |
| Quick Ratio (X) | 4.77 | 3.42 | 3.30 | 2.44 | 2.93 | |
| Inventory Turnover Ratio (X) | 6.04 | 0.72 | 0.63 | 0.69 | 0.56 | |
| Dividend Payout Ratio (NP) (%) | 5.70 | 12.25 | 14.03 | 48.29 | 25.81 | |
| Dividend Payout Ratio (CP) (%) | 5.06 | 10.80 | 11.42 | 26.26 | 20.40 | |
| Earnings Retention Ratio (%) | 94.30 | 87.75 | 85.97 | 51.71 | 74.19 | |
| Cash Earnings Retention Ratio (%) | 94.94 | 89.20 | 88.58 | 73.74 | 79.60 | |
| Coverage Ratios | ||||||
| Interest Coverage Ratios (%) | 106.72 | 97.89 | 71.74 | 20.48 | 53.37 | |
| Interest Coverage Ratios (Post Tax) (%) | 106.72 | 97.89 | 71.74 | 20.48 | 53.37 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 12,381.23 | 16,442.15 | 9,905.31 | 14,018.63 | 15,043.09 | |
| EV/Net Operating Revenue (X) | 2.80 | 4.11 | 3.66 | 7.21 | 7.33 | |
| EV/EBITDA (X) | 4.85 | 8.75 | 9.52 | 38.67 | 21.19 | |
| MarketCap/Net Operating Revenue (X) | 3.22 | 4.26 | 3.80 | 7.11 | 7.34 | |
| Retention Ratios (%) | 94.29 | 87.74 | 85.96 | 51.70 | 74.18 | |
| Price/BV (X) | 1.88 | 2.91 | 2.11 | 3.24 | 3.65 | |
| Price/Net Operating Revenue | 3.22 | 4.26 | 3.80 | 7.11 | 7.34 | |
| Earnings Yield | 0.13 | 0.08 | 0.07 | 0.01 | 0.03 |
26.11.2025
Natco Pharma Consolidated September 2025 Net Sales at Rs 1,363.00 crore, down 0.59% Y-o-Y
24.11.2025
Natco Pharma Standalone September 2025 Net Sales at Rs 1,264.30 crore, down 2.19% Y-o-Y
24.11.2025
24.11.2025
26.11.2025
Natco Pharma Consolidated September 2025 Net Sales at Rs 1,363.00 crore, down 0.59% Y-o-Y
24.11.2025
Natco Pharma Standalone September 2025 Net Sales at Rs 1,264.30 crore, down 2.19% Y-o-Y
14.11.2025
Natco Pharma Consolidated September 2025 Net Sales at Rs 1,363.00 crore, down 0.59% Y-o-Y
09.09.2025
Natco Pharma Standalone June 2025 Net Sales at Rs 1,192.70 crore, down 3.57% Y-o-Y